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ABSTRACT 
BACKGROUND: Stress-induced or Tako-Tsubo Cardiomyopathy (TTC) is a rare acute cardiac 
syndrome characterized by transient left ventricular (LV) dysfunction of uncertain aetiology and 
outcome. PURPOSE: This study sought to assess the long-term outcome of TTC patients. 
METHODS: One-hundred and sixteen consecutive patients were prospectively included in the study 
and observed at long-term follow-up. Primary endpoints were: death, TTC recurrence and 
hospitalization from any cause. RESULTS: Mean initial LV ejection fraction (EF) at admission was 
36±9%. Two patients died during hospitalization due to refractory heart failure. All patients who 
were discharged alive but 1 showed complete LV functional recovery. At follow-up (2.0±1.3 years), 
only 64 (55%) patients were asymptomatic. Rehospitalization rate was high (25%) with chest pain 
(n=6) and dyspnea (n=5) as the most common causes. Only 2 patients had a recurrence of TTC. 
Eleven patients died (7 from cardiovascular cause). There was no significant difference in mortality 
(12% vs 7%; p=0.284) and in the other clinical events between patients with and without severe LV 
dysfunction at presentation (LV EF ≤ 35%). Mortality observed in TTC patients was compared to 
age and gender specific mortality of the general population using the standardized mortality ratio 
(SMR) method. The SMR resulted 3.40 (95% CI 1.83-6.34) in TTC population. The only 
independent predictor of death at Cox analysis was Charlson comorbidity index (HR 1.786; 
p=0.0001), but initial LV dysfunction degree was not. CONCLUSION: The recurrence of TTC is 
rare, while recurrences of chest pain or dyspnea are common in TTC patients and frequently lead to 
hospital readmission. Long-term mortality is higher as compared with the control general 
population and at least in part related to patient’s comorbidities. Initial LV dysfunction severity 
seems not to impact long-term event rates. 
 
 
Key words: tako-tsubo cardiomyopathy; acute coronary syndrome; stress; outcome.  
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INTRODUCTION 
Stress-induced or Tako-Tsubo cardiomyopathy (TTC) is a relatively rare acute cardiac 
syndrome, largely confined to female gender and often associated with a stressful event, that may 
mimic a ST-elevation acute myocardial infarction (STEMI). Chest pain or dyspnea, ischemic 
electrocardiographic changes, transient left ventricular (LV) dysfunction and limited release of 
cardiac injury markers, in the absence of epicardial coronary artery disease (CAD) characterize 
TTC acute phase.1-6 In the majority of cases, transient LV dysfunction, which is myocardial 
stunning related, involves the LV apical segments and has a full recovery within few weeks. Direct 
and indirect catecholamine-induced myocardial injury has been indicated as the main and more 
likely pathogenetic mechanism.1-3, 7 The long-term optimal management and outcome of this 
cardiac syndrome are unknown. This study sought to evaluate the long-term clinical outcome of 
TTC patients.  
METHODS 
Participants. We prospectively enrolled patients admitted to the 5 hospitals of our urban area, who 
met all the 4 currently accepted diagnostic criteria for TTC:  (1) transient hypokinesis, akinesis or 
diskinesis of the LV mid segments with or without apical involvement; the regional wall-motion 
abnormalities extend beyond a single epicardial vascular distribution; a stressful trigger is often, but 
not always present; (2) new ECG abnormalities (either ST-segment or T-wave inversion) or modest 
elevation in cardiac troponin; (3) absence of obstructive CAD or angiographic evidence of 
thrombosis or plaque rupture; (4) absence of pheochromocytoma, myocarditis, hypertrophic 
cardiomyopathy.1 The study was approved by the Careggi Hospital Ethic Committee (approval 
number 0028728) and all patients provided informed consent. 
Design. Prospective, multicentre, observational registry. 
Measurements. All patients were admitted to the cardiac care unit after coronary angiography. 
Currently recommended treatments for acute coronary syndromes, with therapy directed at relieving 
myocardial ischemia and preventing thrombotic complications, were provided to TTC patients. For 
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each patients, the Charlson score Index,8 that represent the most studied and valuated comorbidity 
index, was calculated.  
The clinical definition of cardiogenic shock was sustained hypotension (systolic blood pressure <90 
mm Hg for at least 30 minutes) and a reduced cardiac index (<2.2 L/min per m2) in the presence of 
elevated pulmonary capillary occlusion pressure (>15 mm Hg) and tissue hypoxia, including 
oliguria, clouded sensorium, and cool, mottled extremities.  
Outcomes. LV function was evaluated in all patients by two-dimensional echocardiography at 
admission and at discharge. Following discharge, patients were asked to return to our outpatient 
clinic for follow-up evaluation at 1 and 6 months, and annually thereafter. All other possible 
information derived from hospital readmission, or by the referring physician, relatives or 
municipality live registries were collected. Primary endpoints were: death, TTC recurrence and 
rehospitalization for any cause. Sudden death was defined as an unexpected death that occurs within 
1 hour after symptom onset, with or without pre-existing stable clinical conditions. Cardiovascular 
death was defined as sudden death or death caused by reinfarction, heart failure, arrhythmia, or fatal 
vascular disease including stroke. The cause of death was assigned by the event adjudication 
committee consensus. At follow-up visit, dyspnea was classified according to the New York Heart 
Association (NYHA) functional classification system (from Class I = no limitation of physical 
activity to Class IV = unable to carry out any physical activity without dyspnea).  
Statistical analysis. Continuous data are expressed as mean ± standard deviation, and categorical 
data as proportions (%). Data were compared by means of the χ2  test for categorical variables and 
unpaired t test for continuous variables. Cox proportional-hazards multivariate regression analysis 
was used to identify independent predictors of death among TTC patients. Hazard ratios (HR) and 
95% confidence intervals (CI) were calculated. Furthermore, the multivariate Cox model was used 
to compare the mortality observed in TTC series (females only) with the mortality observed in 
women with STEMI admitted to the same hospitals and included in a contemporary prospective 
registry,9 adjusting for age and risk factors and the presence of shock at hospital arrival. Finally, 
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mortality observed in TTC and in STEMI patients were compared to age and gender specific 
mortality of the general population of the same area using the standardized mortality ratio (SMR) 
method.10 A value of p<0.05 was considered significant. Statistical analyses were performed with 
SPSS 11.5 (SPSS Inc., Chicago, Illinois, USA) and STATA 9 (StataCorp. College Station, Texas, 
USA). 
RESULTS 
Baseline characteristics. From July 2003 to March 2008, among 3882 patients (1077 women) 
hospitalized for acute myocardial infarction, 116 patients with TTC were included in the Registry. 
Among TTC patients, an emotional or a physical stressful event was detected in 45 (39%) and 34 
(29%) patients, respectively. Baseline clinical, electrocardiographic and echocardiographic findings 
are reported in Table 1. Urgent angiography showed no significant CAD in patients with TTC. In 
particular, 92 patients (79%) had truly normal coronary arteries, whereas 24 (21%) had ≤50% 
coronary stenosis. Poor distal run-off was observed in 27 patients (23%), whereas no patient 
showed coronary calcification or ectasic CAD. Associated comorbidities were detected in 94 
patients; of these chronic obstructive pulmonary disease was the more frequent (n=20; Table 1). 
Mean LV ejection fraction (EF) at admission was 36±9%. All patients with TTC who were 
discharged alive but 1 showed complete LV functional recovery (LV EF>50%) during follow-up. 
The only patient who failed to recover a normal LV function had a pre-existing hypertension-related 
LV hypertrophy with mild systolic dysfunction. Mean interval time from admission to LV 
functional recovery was 8±7 days.  
Outcomes. Table 2 summarizes in-hospital and long-term clinical outcomes. Two patients died 
during hospitalization due to refractory heart failure. The first patient who died in-hospital was a 
85-year old woman with a traumatic femoral fracture and chronic obstructive pulmonary disease 
who developed chest pain and the classic clinical features of TTC confirmed by angiography. LV 
dysfunction was severe (EF 30%) and associated with moderate to severe functional mitral 
regurgitation. This patient developed refractory cardiogenic shock that did not improve with 
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inotropic drugs or balloon pump and the patient died 24 hours after TTC diagnosis. The second 
patient who died in-hospital was a 80-years old woman with myasthenia gravis that after TTC 
presentation developed cardiac and respiratory failure that did not improve with intubation and 
inotropic agents and the patient died 4 days after hospital admission. 
The other in-hospital complications were: unfatal heart failure, cardiogenic shock, cardiac 
arrhythmias, LV thrombosis, functional mitral regurgitation and LV outflow tract obstruction. 
Long-term follow-up rate was 100%; follow-up length was 2.0±1.3 years. Two thirds of patients 
(n=78) had a survival free from major adverse events; of these, 64 (55%) were truly asymptomatic, 
while 14 (12%) had chest pain episodes. One third of patients (n=38) experienced a major adverse 
event. There were 11 deaths (9%; Table 3). Seven (6%) deaths were classified as cardiovascular: 2 
patients died during the index hospitalization from refractory heart failure; 2 patients had fatal 
ischemic strokes; and 3 patients had an out-of-hospital sudden death (2 of them were on beta-
blockers therapy). TTC recurrence was excluded in the 2 patients with fatal ischemic strokes. Four 
deaths were considered non cardiovascular and were due to chronic obstructive pulmonary disease 
(n=2), pneumonia (n=1), and sepsis (n=1). There was no significant difference in mortality 
(p=0.284) and in the other clinical events between patients with an initial LV EF ≤35% and those 
with a LV EF > 35% (after excluding the 2 patients who died during hospitalization the out-of-
hospital mortality rates were 9% and 7%; p=0.694). Two patients experienced TTC recurrence 
during follow-up. The first patient was a 64-year old woman who had the fist episode of TTC in 
June 2005 following confrontation and argument with the neighbours. She completely recovered 
LV function and was asymptomatic for 3 years with calcium-channel blockers therapy. However, in 
2008 following a new quarrel with the neighbours she presented again a classic TTC episode.  The 
second patient with TTC recurrence was a 66-year old woman smoker with hypertension who 
developed a TTC episode after a burglary at her home. She recovered completely, but one year after 
she developed a new TTC episode while she was waiting for an uterus surgery. Fifteen patients had 
a rehospitalization that was classified as cardiovascular (chest pain [n=6], dyspnea [n=4], heart 
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failure, atrial fibrillation, hypertensive state, and TTC recurrences). There were also 13 cases of non 
cardiovascular rehospitalization, mainly related to comorbidities. Six patients had hospital 
admission due to COPD exacerbation. No outcome difference was observed between patient with 
and without an antecedent stressful event before the index episode. By Cox analysis, the only 
independent predictor of death was Charlson comorbidity index (HR 1.786 [95%CI: 1.299-2.456]; 
p=0.0001), but initial LV dysfunction degree was not. The SMR in patients with TTC was 3.40 
(95%CI 1.83-6.34). The SMR in patients with STEMI admitted to the same hospitals in the same 
period and included in a contemporary prospective registry 9 was 5.17 (95%CI 4.19-6.37). The 
adjusted HR of TTC cases versus STEMI patients was 0.48 (95% CI 0.25-0.94; p=0.016). 
Effect of beta-blockers recommendation. There was no significant difference in all the baseline 
characteristics between patient with (n=81) and without (n=35) beta-blockers recommended at 
discharge. A lower but not significant mortality was observed at long-term follow-up in patients 
with beta-blockers recommended at discharge as compared with those without (Table 2). However, 
patients with beta-blockers showed a trend towards a higher rehospitalization rate, mainly driven by 
non cardiovascular rehospitalizations (Table 2). One patient treated with beta-blockers experienced 
TTC recurrence. 
 
DISCUSSION 
Few but important findings related to the natural history of stress-induced or TTC emerge 
from the analysis of the reported data: 1) TTC recurrence is rare; 2) recurrences of chest pain and 
dyspnea are common in these patients and lead to frequent rehospitalizations, 3) TTC mortality rate 
is higher than the expected mortality in the general population, 4) long-term mortality in TTC seems 
to be not influenced by the initial LV dysfunction severity. 
Previous TTC outcome data derived mainly from retrospective study with small populations 
and limited periods of observation. In our prospective Registry, almost all of the patients admitted 
to hospital for TTC (98.3%) were discharged alive and presented complete LV functional recovery 
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within few days or weeks. TTC recurrence was documented in only 2 patients (1.7%). This 
percentage is relatively low as compared with previous reports.5-6 However, recurrence of any type 
of chest pain (either typical or atypical) and/or dyspnea were frequently presented by patients who 
suffered TTC and generated challenging differential diagnoses. The electrocardiographic and 
echocardiographic findings and cardiac injury marker evaluations were crucial to detect or rule out 
the TTC recurrence. As expected by the advanced age of these patients, rehospitalizations were 
common and mainly related to comorbidities.  
The analysis of the SMR revealed that TTC patients are 3 times more likely to die when 
compared with the general population. This finding must be confirmed in larger study population. 
However, TTC seems to be associated with a long-term survival rate that is intermediate between 
the one of the general population and the one of patients with STEMI.4 Comorbidity (Charlson 
Index) was the only predictor of mortality in the TTC population, and we can speculate that the 
observed mortality excess may be at least in part related to the associated diseases. After discharge, 
the incidence of sudden death (2.6%) was not negligible and it merits further consideration. At the 
present time there is no data available to recommend proper preventive strategies beside an accurate 
patient follow-up, an aggressive treatment of cardiovascular risk factors and an optimal 
management of comorbidities. 
 Interestingly, the severity of initial LV dysfunction seems not to impact long-term survival, 
since LV fully recovers in almost all of the patients. However, severe LV dysfunction, especially 
when associated with functional mitral regurgitation, has been identified as a potent predictor of 
hazardous clinical manifestations, including pulmonary edema and cardiogenic shock in the TTC 
acute phase.11 
Beta-blockers therapy that is actually recommended in the majority of TTC, given the hypothesis of 
a cathecholamine-induced myocardial injury, seems not to completely prevent the recurrence of 
TTC; in fact, one patient had a TTC recurrence during beta-blockers therapy. Moreover, 63 of the 
enrolled patients had a previous hypertension and 17 of them were tacking beta-blockers at the time 
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of the index event. Thus, we can conclude that further data are needed to establish the value of beta-
blockers therapy during long-term follow-up after TTC. On the other hand, the in-hospital use of 
beta-blockers in patients with LV dysfunction and LV outflow tract obstruction is mandatory.12 
Study limitations. Our results must be evaluated in the light of some study limitations. First, true 
TTC natural history should include syndrome recurrence in patients with subclinical presentation as 
well as in patients with out of hospital sudden death. Unfortunately, autopsy data of patients who 
died suddenly were not available. Second, even if it seems unlikely, we can not exclude the 
contribution of atherosclerotic CAD development to the higher mortality rate of TTC as compared 
with the one of the general population. In fact, endothelial dysfunction, that constitute the first step 
of atherosclerosis, has been suggested to be present in TTC.2  Finally, due to the nonrandomized 
nature of the study data on beta-blockers therapy are not conclusive and are only hypothesis 
generating. 
Conclusions. The recurrence of TTC is rare, while recurrences of chest pain or dyspnea are 
common in TTC patients and lead to frequent rehospitalizations. Long-term mortality is higher as 
compared with the control general population and at least in part related to patient’s comorbidities. 
Initial LV dysfunction severity seems not to impact long-term event rates. 
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 TABLE 1. Baseline characteristics of study patients  
 
Variable Tako-tsubo 
Cardiomyopathy 
(n=116) 
 
With antecedent stress 
 
 
  Yes  
n=79   
No  
n=37  
p value 
Age (years) 
Female gender 
Hypertension 
Diabetes mellitus 
Dyslipidemia 
Smokers 
Antecedent stressful event 
Associated disorders* 
Chest pain at presentation 
ST-segment elevation at 
presentation 
Left ventricular ejection fraction at 
admission (%) 
Left ventricular apical dysfunction 
Peak serum creatine kinase value 
(U/L; median-IQ) 
Killip class III or IV 
Therapy recommended at discharge 
   Beta-blockers 
   ACE-Inhibitors 
   Statins 
   Calcium channel blockers 
73±10 
106 (91%) 
63 (54%) 
10 (9%) 
35 (30%) 
28 (24%) 
79 (69%) 
94 (81%) 
85 (72%) 
70 (60%) 
 
36±9 
106 (91%) 
 
310 ± 376 
20 (17%) 
 
81 (70%) 
83 (72%) 
51 (44%) 
10 (9%) 
74±8 
73 (92%) 
43 (54%) 
7 (9%) 
24 (30%) 
17 (21%) 
79 (100%) 
62 (78%) 
59 (75%) 
53 (67%) 
 
37±9 
71 (90%) 
 
282 ± 298 
13 (16%) 
 
53 (67%) 
57 (72%) 
39 (51%) 
8 (10%) 
73±9 
33 (89%) 
20 (54%) 
3 (8%) 
11 (30%) 
11 (30%) 
0 (0%) 
32 (86%) 
26 (70%) 
18 (49%) 
 
35±10 
35 (94%) 
 
371 ± 508 
7 (19%) 
 
28 (76%) 
26 (70%) 
12 (32%) 
2 (5%) 
0.850 
0.565 
0.970 
0.893 
0.943 
0.335 
0.001 
0.163 
0.883 
0.104 
 
0.358 
0.713 
 
0.269 
0.107 
 
0.555 
0.256 
0.067 
0.378 
*Chronic obstructive pulmonary disease (20)             Chronic renal insufficiency (5)          Chronic anemia (2) 
 Atrial fibrillation (12)                                                 Chronic Hepatitis (4)                          Still’s disease (1)                     
 Cancer (11)                                                                 Sjögren disease (3)                              Epilepsy  (1) 
 TIA/Stroke (9)                                                            Valvular disease (3)                            Allergy (1)      
 Thyroid disease (9)                                                     Myasthenia gravis (2)                         Sclerodermia (1) 
Anxiety/depression (8 )                                               Gastric ulcer (2)                                           
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TABLE 2. In-hospital and long-term follow-up clinical outcomes. 
 
Beta-blockers at discharge   
 
Tako-tsubo 
Cardiomyopathy 
(n=116) 
Yes 
(n=81) 
No 
 (n=35) 
p value 
 
In-hospital follow-up 
Death 
Heart failure 
Cardiogenic shock 
Atrial fibrillation 
Ventricular arrhythmia 
Left ventricular thrombosis 
Severe mitral regurgitation 
Left ventricular outflow 
tract obstruction 
2 (2%) 
20 (17%) 
6 (5%) 
7 (6%) 
1 (1%) 
2 (2%) 
18 (16%) 
4 (3%) 
1 (1%) 
14 (17%) 
4 (5%) 
4 (5%) 
1 (1%) 
1 (1%) 
14 (17%) 
4 (5%) 
 
1 (1%) 
6 (17%) 
2 (6%) 
3 (8%) 
0 (0%) 
1 (3%) 
4 (11%) 
0 (0%) 
 
0.514 
0.985 
0.862 
0.450 
0.999 
0.537 
0.424 
0.001 
 
Long-term follow-up 
Follow-up length (months) 
 
Death 
    cardiovascular 
    non cardiovascular 
Tako-tsubo cardiomyopathy 
recurrence 
NYHA classification 
Rehospitalization 
    cardiovascular 
    non cardiovascular 
Atypical chest pain 
24±15 
 
11 (9%) 
7 (6%) 
4 (3%) 
2 (2%) 
 
1.6±0.8 
28 (25%) 
15 (13%) 
13 (12%) 
16 (14%) 
22±14 
 
6 (8%) 
3 (4%) 
3 (4%) 
1 (1%) 
 
1.5±0.8 
23 (32%) 
10 (12%) 
11 (14%) 
13 (16%) 
27±16 
 
5 (14%) 
4 (11%) 
1 (1%) 
1 (3%) 
 
1.9±0.8 
5 (15%) 
5 (15%) 
2 (6%) 
3 (8%) 
0.131 
 
0.264 
0.108 
0.818 
0.514 
 
0.005 
0.071 
0.775 
0.217 
0.382 
NYHA: New York Heart Association 
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TABLE 3: Characteristics of patients who died. 
 
 
 
1 2 3 4 5 6 7 8 9 10 11 
Age (years) 85 80 72 83 89 73 77 76 82 68 81 
Female gender + + + + + 0 + + + + + 
Hypertension 0 0 0 + 0 + + 0 + 0 + 
Associated 
disorders 
COPD Myasthenia 
gravis 
Previous 
Stroke 
0 Previous 
Stroke, 
PAF 
Previous 
Stroke 
COPD, 
Thyroid 
disease 
COPD, 
Thyroid 
disease 
Previous 
Stroke, 
PAF 
CRI COPD, 
CRI  
Stressful event 
before TTC 
 
Traumatic 
femoral 
fracture 
UNK None Fear for 
surgery 
Trauma   None COPD 
exacerba 
tion 
None Death of a 
relative  
Starting 
dialysis 
Nose 
bleed 
Mitral 
regurgitation 
grade 
+++ + ++ + ++ + + + ++ +++ ++ 
ST-segment 
elevation 
+ + + 0 0 0 + + + 0 0 
Peak serum CK 
value U/L  
101 255 67 68 247 2572 91 245 766 30 406 
LVEF at 
admission (%) 
30 40 35 40 40 25 30 15 28 30 40 
LVEF at 
discharge (%) 
- - 55 50 45 55 60 60 37 48 40 
LVEF at last FU 
(%) 
30 48 55 55 60 55 60 58 50 53 57 
Time of death 
(days) 
1 4 121 200 210 295 426 541 563 570 769 
Cause of death 
 
Acute HF 
 
HF and RF 
 
SD Sepsis 
 
Pneumo
nia 
Stroke COPD SD Stroke SD COPD 
Stressful event 
before death 
NA NA Severe 
disabilit
y 
0 0 UNK 0 0 UNK Sympto
matic 
PAD 
UNK 
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UNK: unknown; NA: not applicable; LV EF: left ventricular ejection fraction; CK: creatine kinase; 
COPD: chronic obstructive pulmonary disease; HF: heart failure; RF: Respiratory failure; TTC: 
Tako-tsubo Cardiomyopathy; SD: sudden death; FU: follow-up, PAF: Parossistic atrial fibrillation, 
CRI: Chronic renal insufficiency, PAD: Peripheral artery disease 
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